Effect of earlier initiation of antiretroviral treatment and increased treatment coverage on HIV-related mortality in China: a national observational cohort studyFujie Zhang
Division of Treatment and Care, National Centre for AIDS STD Control and Prevention, Chinese Centre for Disease Control and Prevention, Beijing, China
Lancet Infect Dis 11:516-24. 2011
..Overall HIV mortality rates in China have not been reported. In this analysis we assess overall mortality in treatment-eligible adults with HIV and attempt to identify risk factors for HIV-related mortality...
Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational databasePoh Lian Lim
Tan Tock Seng Hospital, Singapore
J Int AIDS Soc 15:1. 2012
..This study examines the proportion of patients in the TREAT Asia HIV Observational Database (TAHOD) receiving PCP prophylaxis, and its effect on PCP and mortality...
- Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors
Kathy Petoumenos
National Centre in HIV Epidemiology and Clinical Research, University of New South Wales, Sydney, NSW, Australia
J Int AIDS Soc 13:51. 2010
..This retrospective survey describes types of cancers diagnosed in HIV-infected subjects in Asia, and assesses risk factors for cancer in HIV-infected subjects using contemporaneous HIV-infected controls without cancer...
- Association between missed early visits and mortality among patients of china national free antiretroviral treatment cohort
Yao Zhang
Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, PR China
J Acquir Immune Defic Syndr 60:59-67. 2012
..However, few studies have evaluated indicators for patient access to medical care and their association with mortality...
- The effect of highly active antiretroviral therapy on mortality among HIV-infected former plasma donors in China
Fujie Zhang
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Ditan Hospital, Beijing, China
Clin Infect Dis 47:825-33. 2008
..Highly active antiretroviral therapy (HAART) was provided for former plasma donors beginning in 2002. The effect of HAART on mortality in this cohort has not been described...
Five-year outcomes of the China National Free Antiretroviral Treatment ProgramFujie Zhang
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Ann Intern Med 151:241-51, W-52. 2009
..China's National Free Antiretroviral Treatment Program began in 2002 and, by August 2008, included more than 52 000 patients...
- Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008
Zhihui Dou
Chinese Center for Disease Control and Prevention, Beijing, China
PLoS ONE 6:e22707. 2011
..Gender differences, however, in mortality and immunological response to ART in this cohort have never been described...
- Predictors of virologic failure in HIV-1-infected adults receiving first-line antiretroviral therapy in 8 provinces in China
Ye Ma
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, US Embassy, Beijing, China
Clin Infect Dis 50:264-71. 2010
..Despite poor primary health care systems, free antiretroviral therapy (ART) has been available in China for >5 years. Virologic outcomes in Chinese patients receiving ART have not been described on a national level...
- The Chinese free antiretroviral treatment program: challenges and responses
Fujie Zhang
National Center for AIDS STD Control and Prevention Chinese Center for Disease Control and Prevention, Beijing, China
AIDS 21:S143-8. 2007
..The Free ART Program has made considerable progress in providing the necessary care and treatment for HIV-infected people in China and has strong government support for continued improvement and expansion...
- Monitoring HIV drug resistance using early warning indicators in China: results from a pilot survey conducted in 2008
Ye Ma
Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
Clin Infect Dis 54:S300-2. 2012
..HIV drug resistance early warning indicator monitoring provides a valuable assessment of ART service delivery, and its application will be scaled up throughout China...
- Progress of the National Pediatric Free Antiretroviral Therapy program in China
Yan Zhao
National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, Xuan Wu District, China
AIDS Care 22:1182-8. 2010
..Secondly, much of the pediatric ARV drug supply depends on donation. An effort needs to be made by the Chinese Government to establish China's own drug procurement and supply system...
- Hepatitis B and hepatitis C seroprevalence in children receiving antiretroviral therapy for human immunodeficiency virus-1 infection in China, 2005-2009
Shuntai Zhou
Division of Treatment and Care, National Center for AIDS STI Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
J Acquir Immune Defic Syndr 54:191-6. 2010
..In this study, we evaluated the seroprevalence of HBV and HCV in children receiving ART and associated factors...
- HIV-infected former plasma donors in rural Central China: from infection to survival outcomes, 1985-2008
Zhihui Dou
Chinese Center for Disease Control and Prevention, Beijing, China
PLoS ONE 5:e13737. 2010
..The objectives of this study are to estimate the timing and geographic spread of HIV infection in this cohort and to demonstrate the impact of antiretroviral therapy on survival outcomes...
- Quantitatively monitoring AIDS policy implementation in China
Yufen Liu
Chinese Center for Disease Control and Prevention, Beijing, China
Int J Epidemiol 39:ii90-6. 2010
..We tested a hypothesis that incrementally setting realistic quantitative targets for key indicators and monitoring performance would facilitate AIDS policy implementation in China...
- CD14(high)CD16(+) rather than CD14(low)CD16(+) monocytes correlate with disease progression in chronic HIV-infected patients
Junyan Han
Institute of Infectious Diseases, Capital Medical University, Beijing, China
J Acquir Immune Defic Syndr 52:553-9. 2009
..Because CD14(+)CD16(+) monocytes are a heterogeneous population and consist of CD14(high)CD16(+) and CD14(low)CD16(+) subsets, we evaluated the effects of HIV infection on distinct subsets of CD16(+) monocytes...
- Drug resistance profiles among HIV-1-infected children experiencing delayed switch and 12-month efficacy after using second-line antiretroviral therapy: an observational cohort study in rural China
Yan Zhao
Division of Treatment and Care, National Center for AIDS STD Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, China
J Acquir Immune Defic Syndr 58:47-53. 2011
....
- Estimating the number of people living with HIV/AIDS in China: 2003-09
Ning Wang
Chinese Center for Disease Control and Prevention, Beijing, China
Int J Epidemiol 39:ii21-8. 2010
..Subsequent national estimation exercises were carried out in 2005, 2007 and 2009. We describe these estimation processes and present the results of China's HIV/AIDS estimation exercises from 2003 to 2009...
- Chinese pediatric highly active antiretroviral therapy observational cohort: a 1-year analysis of clinical, immunologic, and virologic outcomes
Fujie Zhang
Chinese Center for Disease Control and Prevention, National Center for AIDS, Division of Treatment and Care, Beijing, China
J Acquir Immune Defic Syndr 46:594-8. 2007
..Few data are available on the outcomes of pediatric antiretroviral therapy (ART) in the developing world...
